OXFYY (Oxford Nanopore Technologies) Risk Assessment


OXFYY Oxford Nanopore Technologies PLC OXFYY
50 GF Score
Price $6.50
GF Value $10.39
Valuation Significantly Undervalued
! 2 Warning Signs
View Full Analysis

What is Oxford Nanopore Technologies Risk Assessment?

Risk Assessment represents the investment risk of a stock derived from our exclusive method. It suggests how risky the investment opportunity is based on the valuation and the fundamental performance of the stock. It is derived from following key aspects:

1. GuruFocus internally developed valuations of the stock, such as GF valuation.
2. Quality Rank, a business quality indicator developed by GuruFocus.
3. Fundamental performance: Piotroski F-Score, Altman Z-Score, Beneish M-Score, etc.
4. Growth opportunities: 5-year revenue growth rate, 5-Year EPS without NRI Growth Rate, etc.

Value investors are always willing to find undervalued stocks. However, not all the undervalued stocks are good deals, we should also be careful of how risky the investment opportunity is. We believe that if the company's financial strength and profitability are strong, and the stock price is within a reasonable range of the GF valuation, or stock has a high return with its price being undervalued, then it might be a good investment opportunity with low risk.

Based on those aspects listed above, GuruFocus believes the risk assessment of Oxford Nanopore Technologies is: High Risk: High uncertainty with risk-return tradeoff.

Oxford Nanopore Technologies  (OTCPK:OXFYY) Risk Assessment Explanation

Based on the four aspects listed above, GuruFocus provides the following 7 evaluations:

All-in-One Screener Examples (1)
Low Risk: Strong fundamentals, worth long-term holding
Moderate Risk: Sensitive, better choose undervalued stock
High Risk: High uncertainty with risk-return tradeoff
High Risk: Good fundamentals, beware of shrinking business
High Risk: Sensitive to economic or industry trends
High Risk: High uncertainty
No Data: Cannot be evaluated

(1) These are some simple examples. You can access our Risk Assessment filter under All-in-One Screener’s Fundamental tab and set your own criteria.

Oxford Nanopore Technologies Risk Assessment Related Terms

OXFYY vs VRTX, REGN, ALNY: Risk Assessment Comparison

For the Biotechnology subindustry, Oxford Nanopore Technologies's Risk Assessment, along with its competitors' market caps and Risk Assessment data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Oxford Nanopore Technologies Risk Assessment vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Oxford Nanopore Technologies's Risk Assessment distribution charts can be found below:

* The bar in red indicates where Oxford Nanopore Technologies's Risk Assessment falls into.


OXFYY
50GF Score
Oxford Nanopore Technologies PLC OXFYY
Risk Assessment is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Oxford Nanopore Technologies (OXFYY) Overvalued in 2026?

Based on GuruFocus' analysis, Oxford Nanopore Technologies stock appears to be undervalued. The current stock price of $6.50 is trading 37.4% below its estimated GF Value™ of $10.39. GuruFocus considers Oxford Nanopore Technologies to be Significantly Undervalued.

Key valuation signals for OXFYY:

  • Risk Assessment:
  • GF Value™: $10.39 vs. price of $6.50 (37.4% below fair value)
  • GF Score™: 50/100 with 2 warning signs

No single metric tells the full story. See the OXFYY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Oxford Nanopore Technologies Business Description

Address Edmund Halley Road, Gosling Building, Oxford Science Park, Oxford, Oxfordshire, GBR, OX4 4DQ
Oxford Nanopore Technologies PLC is involved in researching, developing, manufacturing and commercializing deoxyribonucleic acid (DNA) or ribonucleic acid (RNA) sequencing technology that provides rich data, is fast, accessible and easy to use, and which allows the real-time analysis of DNA or RNA. It has developed and brought to market a new generation molecular sensing platform based on nanopores. The first application is DNA/RNA sequencing and the platform is also being developed for the analysis of proteins and metabolites. It operates in single segment of providing products and services related to the sale and use of its nanopore-based sensing technology. Geographically its operations are spread across EMES, AMR, and APAC.
50GF Score

Get the complete analysis for OXFYY

Risk Assessment is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$6.50
Price
$10.39
GF Value